Literature DB >> 25232397

Genetic variation I148M in patatin-like phospholipase 3 gene and risk of non-alcoholic fatty liver disease among Filipinos.

Michael O Baclig1, Jingky P Lozano-Kühne1, Cynthia A Mapua1, Juliet Gopez-Cervantes2, Filipinas F Natividad1.   

Abstract

Genome-wide association studies have shown that a non-synonymous single nucleotide polymorphism characterized by a C-to-G change encoding an isoleucine-to-methionine substitution at amino acid position 148 in the human patatin-like phospholipase 3 (PNPLA3) gene was found to be associated with non-alcoholic fatty liver disease (NAFLD) and advanced liver damage. A hospital-based study was conducted to determine the distribution of PNPLA3 genotypes among patients clinically diagnosed and histologically confirmed with NAFLD and among normal controls. We also compared the allelic frequencies of PNPLA3 with different ethnic populations. More importantly, we evaluated the association between PNPLA3 genetic variation and risk of developing NAFLD among Filipinos. Real-time PCR was performed using the Taqman SNP genotyping assay for rs738409. Nucleotide sequencing was performed to confirm the PNPLA3 genotypes. Allelic frequencies among normal controls were 0.83 and 0.17 for the PNPLA3 C and PNPLA3 G alleles, respectively. Calculated frequencies in Hardy Weinberg Equilibrium were 72% for PNPLA3 C/C, 22% for PNPLA3 C/G, and 6% for PNPLA3 G/G genotype. There is a significant difference in the distribution of PNPLA3 genotypes between normal controls and NAFLD patients (p = 0.0172). However, there was no significant association found between PNPLA3 genotypes and risk of developing NAFLD after controlling for possible confounding effects (p = 0.0574). Allelic frequencies of PNPLA3 among Filipinos were statistically different from Hispanics, Japanese, and Han Chinese. In conclusion, genetic variation in PNPLA3 rs738409 C>G seems to be associated with NAFLD among Filipinos. Further studies are needed to replicate our observations in an independent larger population.

Entities:  

Keywords:  Filipino; Genetic variation; I148M; non-alcoholic fatty liver disease; patatin-like phospholipase 3 gene; rs738409 C>G

Year:  2014        PMID: 25232397      PMCID: PMC4161557     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  33 in total

1.  IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.

Authors:  Salvatore Petta; Stefania Grimaudo; Calogero Cammà; Daniela Cabibi; Vito Di Marco; Giusalba Licata; Rosaria Maria Pipitone; Antonio Craxì
Journal:  J Hepatol       Date:  2012-02-05       Impact factor: 25.083

2.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.

Authors:  Marcin Krawczyk; Frank Grünhage; Vincent Zimmer; Frank Lammert
Journal:  J Hepatol       Date:  2010-12-17       Impact factor: 25.083

4.  Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.

Authors:  Felix Stickel; Stephan Buch; Katharina Lau; Henriette Meyer zu Schwabedissen; Thomas Berg; Monika Ridinger; Marcella Rietschel; Clemens Schafmayer; Felix Braun; Holger Hinrichsen; Rainer Günther; Alexander Arlt; Marcus Seeger; Sebastian Müller; Helmut Karl Seitz; Michael Soyka; Markus Lerch; Frank Lammert; Christoph Sarrazin; Ralf Kubitz; Dieter Häussinger; Claus Hellerbrand; Dieter Bröring; Stefan Schreiber; Falk Kiefer; Rainer Spanagel; Karl Mann; Christian Datz; Michael Krawczak; Norbert Wodarz; Henry Völzke; Jochen Hampe
Journal:  Hepatology       Date:  2010-12-07       Impact factor: 17.425

Review 5.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

6.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

Review 7.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

8.  The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.

Authors:  Luca Valenti; Raffaela Rametta; Massimiliano Ruscica; Paola Dongiovanni; Liliana Steffani; Benedetta Maria Motta; Elena Canavesi; Anna Ludovica Fracanzani; Enrico Mozzi; Giancarlo Roviaro; Paolo Magni; Silvia Fargion
Journal:  BMC Gastroenterol       Date:  2012-08-16       Impact factor: 3.067

9.  Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Authors:  Takahisa Kawaguchi; Yoshio Sumida; Atsushi Umemura; Keitaro Matsuo; Meiko Takahashi; Toshinari Takamura; Kohichiroh Yasui; Toshiji Saibara; Etsuko Hashimoto; Miwa Kawanaka; Sumio Watanabe; Sumio Kawata; Yasuharu Imai; Miki Kokubo; Toshihide Shima; Hyohun Park; Hideo Tanaka; Kazuo Tajima; Ryo Yamada; Fumihiko Matsuda; Takeshi Okanoue
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

10.  Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population.

Authors:  Yiling Li; Chao Xing; Zhong Tian; Hung-Chih Ku
Journal:  BMC Med Genet       Date:  2012-11-23       Impact factor: 2.103

View more
  10 in total

1.  Non-alcoholic fatty liver disease (NAFLD) in Filipino North American patients: Results from a multi-ethnic cohort.

Authors:  Shirley X Jiang; Roberto Trasolini; Michael Heer; Benjamin Cox; Ciaran Galts; Vladimir Marquez; Eric M Yoshida
Journal:  Can Liver J       Date:  2022-02-04

2.  Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.

Authors:  Shahinul Alam; Mohammad Shaiful Islam; Saiful Islam; Golam Mustafa; Ahmed Abu Saleh; Nooruddin Ahmad
Journal:  Indian J Gastroenterol       Date:  2017-10-04

3.  PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum.

Authors:  Habeeb Salameh; Muhannad Al Hanayneh; Maen Masadeh; Mohammed Naseemuddin; Tasnia Matin; Angelika Erwin; Ashwani K Singal
Journal:  J Clin Transl Hepatol       Date:  2016-07-08

4.  CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice.

Authors:  Michael Zimmer; Pradeep Bista; Ericka L Benson; Diana Y Lee; Feng Liu; Dominic Picarella; Rick B Vega; Chi B Vu; Maisy Yeager; Min Ding; Guosheng Liang; Jay D Horton; Robert Kleemann; Teake Kooistra; Martine C Morrison; Peter Y Wielinga; Jill C Milne; Michael R Jirousek; Andrew J Nichols
Journal:  Hepatol Commun       Date:  2017-05-12

5.  PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism.

Authors:  Qin Pan; Mei-Mei Chen; Rui-Nan Zhang; Yu-Qin Wang; Rui-Dan Zheng; Yu-Qiang Mi; Wen-Bin Liu; Feng Shen; Qing Su; Jian-Gao Fan
Journal:  J Diabetes Res       Date:  2017-06-14       Impact factor: 4.011

6.  Association of rs738409 Polymorphism in Adiponutrin Gene with Liver Steatosis and Atherosclerosis Risk Factors in Greek Children and Adolescents.

Authors:  Eleanna Stasinou; Elpida Emmanouilidou-Fotoulaki; Maria Kavga; Fotini Sotiriadou; Alexandros F Lambropoulos; Maria Fotoulaki; Kyriaki Papadopoulou-Legbelou
Journal:  Nutrients       Date:  2022-08-23       Impact factor: 6.706

7.  Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities.

Authors:  Govardhan Bale; Avanthi Urmila Steffie; Vishnubhotla Venkata Ravi Kanth; Padaki Nagaraja Rao; Mithun Sharma; Mitnala Sasikala; Duvvur Nageshwar Reddy
Journal:  World J Hepatol       Date:  2017-09-18

8.  Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.

Authors:  Andras Franko; Dietrich Merkel; Marketa Kovarova; Miriam Hoene; Benjamin A Jaghutriz; Martin Heni; Alfred Königsrainer; Cyrus Papan; Stefan Lehr; Hans-Ulrich Häring; Andreas Peter
Journal:  Nutrients       Date:  2018-09-17       Impact factor: 5.717

Review 9.  PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease.

Authors:  Jin-Zhi Wang; Hai-Xia Cao; Jian-Neng Chen; Qin Pan
Journal:  World J Clin Cases       Date:  2018-08-16       Impact factor: 1.337

10.  Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Nader Salari; Niloufar Darvishi; Kamran Mansouri; Hooman Ghasemi; Melika Hosseinian-Far; Fateme Darvishi; Masoud Mohammadi
Journal:  BMC Endocr Disord       Date:  2021-06-19       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.